Friday, May 1, 2026

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

CGBio Reports Return to Operating Profit in 2025… Growth in Bone Substitutes and Dental Business

CGBio Co., Ltd. reported a $2.6M operating profit in 2025, reversing losses and achieving 36% revenue growth, driven by bone substitutes.

JW Pharmaceutical Advances Gout Treatment with Epaminurad

JW Pharmaceutical advances its gout treatment, Epaminurad, with global trials nearing completion and U.S. patent secured for market entry.

Tag: Air Koryo

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.